• Title/Summary/Keyword: Intravenous Therapy

Search Result 381, Processing Time 0.034 seconds

중소 종합병원 간호사가 인지하는 정맥수액요법의 중요도와 수행정도 (Perceived Importance and Performance of Intravenous Fluid Therapy by Nurses in Small-Medium General Hospitals)

  • 김종임;이지현;장옥자
    • 기본간호학회지
    • /
    • 제20권4호
    • /
    • pp.372-380
    • /
    • 2013
  • Purpose: This study was done to investigate nurses' perceived importance of, and performance of intravenous fluid therapy. Methods: Data were collected from a convenience sample of 234 nurses (return rate: 93%) working in 3 small-medium general hospitals. Results: The score for perceived importance of intravenous fluid therapy ($3.65{\pm}0.37$) was higher than that of performance ($3.45{\pm}0.39$). There were positive correlations between perceived importance and performance (r=.576, p<.001). There were 180 (80.8%) errors in intravenous fluid therapy. Perceived importance and performance scores were higher in nurses who had not experienced medication errors in intravenous fluid therapy. Conclusion: The results indicate a need to develop appropriate strategies to improve perceived importance and performance and enhance safety management during intravenous fluid therapy for nurses in small-medium general hospitals.

신규간호사의 정맥주입요법 교육 현황과 교육요구도 분석 (The Current Status of Intravenous Infusion Therapy Education for New Nurses and Their Needs for the Education)

  • 윤주희;서민정
    • 임상간호연구
    • /
    • 제26권1호
    • /
    • pp.59-74
    • /
    • 2020
  • Purpose: The purpose of this study is to investigate new nurses' needs for intravenous infusion therapy training by analyzing the current training status. Methods: This study examined the needs for intravenous infusion therapy training with 159 new nurses. The measurement tool consisted of 93 items developed based on intravenous therapy-related studies, and was evaluated on a 4-point Likert scale. For data analysis, SPSS/WIN 25.0 was used, and frequency, percentage, average, standard deviation, paired t-test, were performed. Results: The demand for intravenous therapy education was analyzed using a questionnaire composed of 8 areas, 16 sub-areas, and 93 items. According to the findings, post-ward placement intravenous therapy education(83.7%) is conducted more often than in preliminary education (72.2%). The demand for intravenous infusion therapy education did not differ significantly in preliminary and post-ward placement education (t=-.89, p=.376). While therapy skills were preferred in preliminary education, there were high demands for education content related to blood transfusion, central venous catheter, and drug use in continuing education. As for preferred teaching methods, lecture (38.2%) and simulation (26.7%) were most answered for preliminary education, while a range of methods were preferred for continuing education including lecture (31.1%), clinical practice (20.6%), preceptor training (19.8%), simulation (16.8%), and self-study (11.6%). Conclusion: For efficient training, it is required to provide different education contents and methods for each stage.

영아 비후성 유문 협착증의 atropine sulfate 정맥요법 (Intravenous Atropine Sulfate Therapy for Infantile Hypertrophic Pyloric Stenosis)

  • 방승호;강윤중;조병선;이태석
    • Advances in pediatric surgery
    • /
    • 제8권1호
    • /
    • pp.33-38
    • /
    • 2002
  • The purpose of this study is to evaluate the applicability of intravenous atropine sulfate therapy in infantile hypertrophic pyloric stenosis (IHPS). From 1998 to 2000 among 35 cases of IHPS, pyloromytomy was performed in 13 (Group A), and intravenous atropine was given as a primary therapy in 22 cases (Group B). In group A, all cases were cured completely. In group B, 13 (59 %) out of 22 cases were successfully treated with atropine, but 9 were failed therapy, and required operation. The recovery period to normal feeding and the hospital stay of the successful atropine group were longer than those of pyloromyotomy, 8.6 days vs. 2.9 days and 13.2 days vs. 4.1 days, respectively. In conclusion, intravenous atropine therapy did not replace pyloromyotomy, but it might be an alternative for the selected patients with contraindications for operation.

  • PDF

급성기 뇌경색 환자에서 한방치료와 지속적 유로키나제 정주요법 병용시 안전성에 대한 임상적 고찰 (Study for Safety of Oriental Medical Therapy and Continuous Intravenous Urokinase combined Therapy in Acute Cerebral Infarction.)

  • 김성근;임창선;임준혁;양동호;신현승;박준하;정승철
    • 대한중풍순환신경학회지
    • /
    • 제10권1호
    • /
    • pp.1-7
    • /
    • 2009
  • Objectives : This Study was prepared for investigating the safety of oriental medicine and continuous intravenous urokinase combined therapy in acute cerebral infarction. Methods : We prospectively estimate safety of hemorrhagic transformation occurred in oriental medical therapy and continuous intravenous urokinase combined therapy. We estimate National Institute of Health Stroke Scale Score and Modified Barthel Index. Results : Hemorrhagic transformation was not noted. and Others are not fatal complication. Conclusions : oriental medical therapy and continuous intravenous urokinase combined therapy are safety method in treatment of acute cerebral infarction. We think this can be a good model of Oriental and western cooperative therapy.

  • PDF

신경근질환의 정맥 내 면역글로불린 치료와 연관된 유해사례 (Adverse Events Associated with Intravenous Immunoglobulin Therapy in Neuromuscular Disorders)

  • 나상준;최영철
    • Annals of Clinical Neurophysiology
    • /
    • 제8권1호
    • /
    • pp.48-52
    • /
    • 2006
  • Background: Intravenous immunoglobulin (IVIg) has been administered for various immune-mediated neurological diseases such as autoimmune neuropathy, inflammatory myopathies, and other autoimmune neuromuscular disorders. The purpose of this study is to investigate side effects and complications of IVIg therapy in neuromuscular disorders. Methods: We enrolled 29 patients (age 8~63 years) with IVIg therapy for various neurological diseases including Guillain-Barre syndrome, myasthenia gravis, dermatomyositis, polymyositis, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. IVIg therapy was used at a dose of 0.4 g/kg body weight/day for 5 consecutive days. Results: 10 patients (34%) had adverse events. There are adverse events in 16 courses (11%) among total 145 courses. The majority of patients presented with mild side effects, mostly asymptomatic laboratory changes. Rash or mild headache occurred in 3 patients. One patient showed a serious side effect of deep vein thrombosis. Conclusions: IVIg therapy is safe for a variety of immune-mediated neurological diseases in our study.

  • PDF

광센서 기반 휴대형 침윤 조기 감지기 개발 (A Development of Portable Early Detector of Intravenous Infiltration based on Optical Sensor)

  • 이성진;신범주;정인숙
    • 한국멀티미디어학회논문지
    • /
    • 제21권6호
    • /
    • pp.705-711
    • /
    • 2018
  • Intravenous(IV) therapy being in use for many patients may cause serious side effects such as infiltration, extravasation. To minimize such side effects, it is important to detect symptoms appearing when fluid escapes from blood vessel to tissue as soon as possible. This paper describes a device which has been developed to detect IV infiltration early using optical sensor. The device detects IV infiltration as measuring intensity of lights reflected from that lights after emitting lights in IV therapy site. The lights are consisted of 4 different waves which provide different reflection ratio depending the fluid used in IV therapy. The experimental results show that the device can be used to detect IV infiltration early.

정맥주사용 수액의 개방후 시간경과에 따른 오염도에 관한 실험연구 (A Study on the Relationship Between Length of Time and Contamination in Open Intravenous Solutions)

  • 김일원
    • 대한간호학회지
    • /
    • 제16권1호
    • /
    • pp.67-80
    • /
    • 1986
  • The use of intravenous solutions for fluid replacement has become an integral part of patient care, This widespread use of intravenous solutions has increased the risk of contamination that can lead to septicemia and phlebitis. The literature regarding contamination of in use intravenous solutions recommends a standard 24-hour time limit on the use of these fluids. But the desings of these studies did not incorporate a time variable related to contamination. In other studies, however, time was a manipulated variable: but data regarding the onset of contamination were conflicting. Because published reports conflict with regard to a time standard related to the use of intravenous therapy, additional empirical data are needed upon which to base the standards of care regulating use of intravenous therapy. This study investigated rate of contamination in simulated in-use intravenous solutions to obtain data from which to recomend a standard time period for the administration of intravenous solutions. In this study samples were drawn from 60 bottles of 5% D/W solution at predetermined time intervals over 48 hours and samples were inoculated to Thio-glychollate Broth. After 10 days' culturing in that Broth, samples were cultured on blood agar plates for 18∼48 hours to determine the rate of contamination. was found at all time Period, regardless of the presence or absence of nurse's gloving in the preparation of fluids, the location in which the experimentations were performed, the contamination level of surrounding air, or the length of time during which solutions were opened. Data from this study support the use of a 48-hour time period on which to base the standard involved in ready-to-use simple intravenous solutions without additives. In emergency departments and critical care areas where intravenous solutions are prepared in advance, the suggested time standard supported by the data generated from this study is 48 hours, not 24 hour. Data from this study support a 24-hour time standard for changing in-use intravenous solutions when the contamination results from the manipulation of intravenous infusion system by hospital personnel, or from some other exogenous sources during administration. Because contamination that does occur within 48 hours in intravenous solutions must be introduced from some exogenous sources, further empirical studies based on the identification of sources of contamination and factors that affect the rate of contamination, are needed to investigate the currently employed standard of intravenous therapy and to provide the patient with more efficient and safer intravenous thereapy.

  • PDF

음악요법이 경정맥요로조영 검사시 환자의 불안에미치는 영향 (Effects of Music Therapy on Anxiety of Intravenous Urology Patients)

  • 여진동;고인호
    • 한국방사선학회논문지
    • /
    • 제11권2호
    • /
    • pp.95-107
    • /
    • 2017
  • 본 연구는 음악요법이 경정맥요로조영 검사로 인한 불안정도와 검사 시 불편감에 미치는 음악요법의 효과를 파악하고자 시도된 비동등성 대조군 사전-사후 실험설계의 유사 실험이다. "음악요법을 받은 군은 음악요법을 받지 않는 군보다 검사 중 불안 점수가 낮을 것이다"는 음악요법 실시 후 실험군의 불안점수가 대조군의 불안점수와 비교하여 유의한 차이가 있어 채택되었다. "음악요법을 받은 군은 음악요법을 받지 않는 군보다 검사 후 활력징후가 낮을 것이다"는 수축기 혈압, 이완기혈압에 대한 가설은 기각되었지만, 맥박에서는 유의 한 차이가 나타나 부분적으로 채택 되었다. "음악요법을 받은 군은 음악요법을 받지 않는 군보다 주간 적 불편감이 낮을 것이다"는 두 집단 간의 유의한 차이를 보였다. 한편 주관적인 불편 감의 하부요인 중 긴장감 에서만 유의한 차이가 있었으며, 동통, 어지러움, 공포감에서는 유의한 차이가 없었다. 이상의 연구결과로 볼 때 음악요법은 경정맥요로조영 검사 중 환자의 상태불안을 감소시킬 수 있는 유용한 대체검사법이 될 수 있을 것이라고 생각된다.

정맥 내 지질 유탁액 치료 후 성공적으로 회복한 초오 중독 1례 (A Case of Aconite Poisoning Successfully Recovered after Intravenous Fat Emulsion Therapy)

  • 신희준;임훈
    • 대한임상독성학회지
    • /
    • 제14권1호
    • /
    • pp.60-65
    • /
    • 2016
  • Aconitum is a genus of various species of flowering plants that belongs to the Family Ranunculaceae. Most Aconitum sp. have extremely toxic alkaloid substances such as aconitine, mesaconitine and hypaconitine. Among these substances, aconitine can cause fatal cardiotoxicity by activating sodium channels followed by calcium channels in myocardial cells. Even though there have been various therapeutic plans suggested comprising antidotes based on diverse case reports and studies, there is no confirmatory treatment protocol for aconite poisoning. Here, we report an aconite poisoning patient who had refractory ventricular tachyarrhythmia that did not respond to intravenous amiodarone therapies even though they were sustained for over 2 hours, but showed successful recovery following intravenous fat emulsions (IFE) therapy.

  • PDF

급성 허혈성 뇌졸중에 있어 한방치료와 지속적 유로키나제 정주요법과의 병행요법의 효과와 안전성 (Safety and Effect of Oriental Medicine and Continuous Intravenous Urokinase combined Therapy in Acute Ischemic Stroke(open clinical trial))

  • 김태연;조영;이준희;류재환;이범준
    • 대한한방내과학회지
    • /
    • 제22권4호
    • /
    • pp.633-638
    • /
    • 2001
  • Objective : Stroke is the most frequent cause of death in Korea. Because it remains severe disablities disturbing normal life, it is important to carry out intervention preventing from progression of condition in patients with acute ischemic stroke within therapeutic time window. Thus early thrombolysis is beneficial for patients with acute ischemic stroke. However its therapeutic efficacy is not known in combination with oriental medical therapy. In this study, we investigated the safety and the clinical effect of continous intravenous urokinase therapy and oriental medical therapy. Methods : Twenty eight patients with acute onset of ischemic stroke no later than three days received continous infusion of urokinase and oriental medical therapy. We estimated the subjects's neurological deficit and functional status with National institute of Neurologic Disorders and Stroke Scale(NIHSS) and Europian Stroke Scale (ESS) prior to therapy, on day 3, 7, 14 after the starting urokinase therapy and on day at discharge. Results: After day 7, the scores of NIHSS and ESS were improved significantly. There are no differences in therapeutic effects of the interval between onset of stroke and initiation of therapy. Complication were noted in four(14%) patients, but these are not fatal complication and make no neurological deficiency. Conclusion : The results of these investment suggest that continuous intravenous urokinase with oriental medical therapy could be a safe and effective intervention to prevent from progression in acute ischemic stroke. But this findings should be confirmed in multicenter double blind controlled trial.

  • PDF